Clinical Trial Update: Tumor-Infiltrating Lymphocytes After Combination Chemotherapy in Treating Patients With Metastatic Melanoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating tumor-infiltrating lymphocytes after combination chemotherapy in metastatic melanoma; results posted but no definitive efficac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Melanoma
• Malignant Melanoma
• Melanoma

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7 | Phase 2 | Status: COMPLETED | Results posted: 2022-11-10